Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

487 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ixazomib-based regimens for relapsed/refractory multiple myeloma: are real-world data compatible with clinical trial outcomes? A multi-site Israeli registry study.
Cohen YC, Magen H, Lavi N, Gatt ME, Chubar E, Horowitz N, Kreiniz N, Tadmor T, Trestman S, Vitkon R, Rouvio O, Shvetz O, Shaulov A, Ziv-Baran T, Avivi I. Cohen YC, et al. Among authors: horowitz n. Ann Hematol. 2020 Jun;99(6):1273-1281. doi: 10.1007/s00277-020-03985-9. Epub 2020 Mar 20. Ann Hematol. 2020. PMID: 32193630
Daratumumab for relapsed AL amyloidosis-When cumulative real-world data precedes clinical trials: A multisite study and systematic literature review.
Shragai T, Gatt M, Lavie N, Vaxman I, Tadmor T, Rouvio O, Zektser M, Horowitz N, Magen H, Ballan M, Suru C, Luttwak E, Levi S, Ziv-Baran T, Avivi I, Cohen YC. Shragai T, et al. Among authors: horowitz n. Eur J Haematol. 2021 Feb;106(2):184-195. doi: 10.1111/ejh.13535. Epub 2020 Nov 9. Eur J Haematol. 2021. PMID: 33090552
Immunogenicity trends 1 and 3 months after second BNT162B2 vaccination among healthcare workers in Israel.
Shachor-Meyouhas Y, Hussein K, Dabaja-Younis H, Szwarcwort-Cohen M, Almog R, Weissman A, Mekel M, Hyams G, Horowitz NA, Gepstein V, Netzer I, Saban HC, Petersiel N, Tarabeia J, Halberthal M. Shachor-Meyouhas Y, et al. Among authors: horowitz na. Clin Microbiol Infect. 2022 Mar;28(3):450.e1-450.e4. doi: 10.1016/j.cmi.2021.11.014. Epub 2021 Nov 24. Clin Microbiol Infect. 2022. PMID: 34838782 Free PMC article.
In patients with follicular lymphoma, delayed-onset neutropenia induced by anti-CD20 monoclonal antibodies frequently occurs during maintenance therapy and is preferentially associated with obinutuzumab.
Fadaos N, Dor YB, Azoulay T, Leiba R, Sharon-Horesh N, Levi T, Horowitz NA, Tzoran I, Lavi N, Beyar-Katz O, Dann EJ, Zuckerman T, Ringelstein-Harlev S. Fadaos N, et al. Among authors: horowitz na. Ann Hematol. 2024 Dec;103(12):5861-5870. doi: 10.1007/s00277-024-06130-y. Epub 2024 Dec 12. Ann Hematol. 2024. PMID: 39663256
Preventing Severe COVID-19 with Tixagevimab-Cilgavimab in Hematological Patients Treated with Anti-CD20 Monoclonal Antibodies: An International Multicenter Study.
Azuly H, Shafat T, Grupel D, Porges T, Abuhasira R, Belkin A, Deri O, Oster Y, Zahran S, Horwitz E, Horowitz NA, Khatib H, Batista MV, Cortez AC, Brosh-Nissimov T, Segman Y, Ishay L, Cohen R, Atamna A, Spallone A, Chemaly RF, Ramos JC, Chowers M, Rogozin E, Oren NC, Keske Ş, Barchad OW, Nesher L; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV). Azuly H, et al. Among authors: horowitz na. Infect Dis Ther. 2024 Dec 9. doi: 10.1007/s40121-024-01089-9. Online ahead of print. Infect Dis Ther. 2024. PMID: 39652286
Ibrutinib With Bendamustine and Rituximab for Treatment of Patients With Relapsed/Refractory Aggressive B-Cell Lymphoma.
Kedmi M, Ribakovsy E, Benjamini O, Schiby G, Barshack I, Raskin S, Eshet Y, Mehr R, Horowitz N, Gurion R, Goldschmidt N, Perry C, Levi I, Aviv A, Herzog-Tzarfati K, Nagler A, Avigdor A. Kedmi M, et al. Among authors: horowitz n. Hematol Oncol. 2024 Nov;42(6):e70001. doi: 10.1002/hon.70001. Hematol Oncol. 2024. PMID: 39572395 Clinical Trial.
487 results